Home › Funds › Hillsdale Investment Management Inc. › ADPT

Hillsdale Investment Management Inc. position in ADPT

ADAPTIVE BIOTECHNOLOGIES COR · Health Care

Hillsdale Investment Management Inc. reported holding 551,350 shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR) in its Q3 2026 13F filing — a position valued at US$15.9M, representing 0.36% of its reported portfolio and ranking #43 among its reported holdings. Hillsdale Investment Management Inc. has disclosed ADPT holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

Latest position (Q3 2026)551.35K sh
Reported value held$15.93M
Portfolio Weight0.36%
First reportedQ2 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Hillsdale Investment Management Inc.'s ADPT position evolved

Hillsdale Investment Management Inc. first disclosed a stake in ADPT in Q2 2025 at 568,090 shares (US$6.6M). The position peaked in Q3 2026 at 551,350 shares, worth US$15.9M. Across 6 filings, Hillsdale Investment Management Inc. increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 551,350 shares valued at US$15.9M — a reduction of -132,867 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2025 568.09K $6.62M New
Q3 2025 621.79K $9.30M Add
Q4 2025 616.95K $10.02M Reduce
Q1 2026 625.22K $8.68M Add
Q2 2026 684.22K $14.68M Add
Q3 2026 551.35K $15.93M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ADPT and 13F data

ADPT (ADAPTIVE BIOTECHNOLOGIES COR) is a Health Care company. 57 other funds we track also report a position in ADPT — the largest reported positions include Viking Global Investors (US$643.4M), VIKING GLOBAL INVESTORS LP (US$643.4M), Aristotle Atlantic Partners, LLC (US$39.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ADPT

All ADPT fund holders →

FAQ

How long has Hillsdale Investment Management Inc. held ADPT?

Hillsdale Investment Management Inc. has disclosed ADPT holdings in 6 of the last 6 reported quarters, going back to Q2 2025.

What is Hillsdale Investment Management Inc.'s current position in ADPT?

As of Q3 2026, Hillsdale Investment Management Inc. holds 551.35K shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR), valued at $15.93M, representing 0.36% of its reported portfolio and ranking #43.

Has Hillsdale Investment Management Inc. been buying or selling ADPT?

In the latest 13F filing (Q3 2026), Hillsdale Investment Management Inc. reduced its position in ADPT. The position peaked in Q3 2026 at 551.35K shares.

Which other funds hold ADPT?

Other major institutional holders of ADPT include Viking Global Investors, VIKING GLOBAL INVESTORS LP, Aristotle Atlantic Partners, LLC, among 57 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.